MELROSE AREA HOSPITAL CENTRACARE — History
CCN 241330 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$51M
Latest Revenue (FY2022)
+9.8%
Revenue CAGR (3yr)
-1.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $43M | $51M | $51M | +1.9% | +9.8% |
| Operating Expenses | $47M | $51M | $52M | +2.8% | +5.7% |
| Operating Margin | -10.0% | -0.9% | -1.8% | -99.5% | +0.0% |
| Net Income | $-4M | $-0M | $-1M | -103.3% | +0.0% |
| Licensed Beds | 14 | 14 | 14 | +0.0% | +0.0% |
| Total Patient Days | 2,233 | 2,161 | 2,031 | -6.0% | -4.6% |
| Medicare Day % | 40% | 35% | 29% | -17.4% | -14.4% |
| Medicaid Day % | 4% | 6% | 3% | -39.9% | -4.8% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +20.7% ($43M → $51M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+9.8%
This Hospital
+7.6%
State Avg
Latest Margin
-1.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $56M | 2.3% |
| FY2024 (proj) | $60M | 6.4% |
| FY2025 (proj) | $65M | 10.6% |